ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,151 | – | 103 | +1960.0% | 0.00% | – |
| Q1 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 5 | -99.8% | 0.00% | -100.0% |
| Q1 2017 | $95,000 | -57.4% | 3,083 | -53.7% | 0.07% | -58.2% |
| Q4 2016 | $223,000 | +112.4% | 6,663 | +86.1% | 0.16% | +64.6% |
| Q1 2016 | $105,000 | -11.0% | 3,580 | 0.0% | 0.10% | -10.3% |
| Q4 2015 | $118,000 | -33.3% | 3,580 | -26.8% | 0.11% | -32.7% |
| Q3 2015 | $177,000 | -19.5% | 4,888 | 0.0% | 0.16% | -10.2% |
| Q2 2015 | $220,000 | +46.7% | 4,888 | 0.0% | 0.18% | +47.5% |
| Q1 2015 | $150,000 | – | 4,888 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |